Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
WEST LAFAYETTE, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced financial results for the three months (“Q2 FY 2024”) and six months ("YTD FY 2024") ended March 31, 2024.
- The Company completed this in-house integration in the second quarter of fiscal 2024.
- Second Quarter Fiscal 2024 Financial Results (Three Months Ended March 31, 2024)
Revenue decreased 21.5% to $119.0 million in Q2 FY 2024 as compared to $151.5 million in Q2 FY 2023. - Year-to-Date Fiscal 2024 Financial Results (Six Months Ended March 31, 2024)
Revenue decreased 7.2% to $254.5 million in YTD FY 2024 as compared to $274.2 million in YTD FY 2023. - Management will host a conference call on Wednesday, May 15, 2024, at 4:30 pm ET to discuss second quarter results for fiscal 2024.